GLP-1 agents also have been shown in prior studies to improve kidney function
Research suggests that many people regain weight after discontinuing GLP-1 medications, which means you may need to continue treatment indefinitely to maintain weight loss
Pharmaceutical therapy, where indicated, must not be projected in a manner that undermines public health initiatives promoting diet control, physical activity, and preventive healthcare measures, the DCGI advisory stated
Who Isnt a Good Candidate for GLP-1
More serious but rare adverse events include pancreatitis, gallbladder disease, and thyroid C-cell tumours (patients should be advised to report symptoms such as neck mass, dysphagia or persistent hoarseness)
Slow eating and improve awareness while eating 4